ASX:MSB Archives - Money Morning Australia

30/04/2021

Mesoblast Share Price Bounce Back on Positive Trial Data (ASX:MSB)

It seems 2021 continues to be a tough year for the ever-volatile Mesoblast Ltd [ASX:MSB]. Thankfully though, today has brought some relief to shareholders. The MSB share price is up 7.38%...

Ryan Clarkson-Ledward

02/03/2021

Mesoblast Share Price Down — Secures a Dire Cash Injection (ASX:MSB)

Seven months ago Mesoblast Ltd [ASX:MSB] was on a tear. This high-flying biotech looked like it had the makings of something great. Today though, that couldn't be further from the truth. The MSB share price is down 5.08%.

Ryan Clarkson-Ledward

18/12/2020

Mesoblast Share Price Crushed as Clinical Trial is Brought to a Halt

The Mesoblast Ltd [ASX:MSB] share price has been absolutely hammered today, trading 32.63% lower at time of writing. The result comes as the company shared some disheartening news. The trial of its remestemcel-L therapy...

Lachlann Tierney

15/12/2020

Mesoblast Share Price Crashes on Heart Failure Therapy Results

Mesoblast Ltd [ASX:MSB] shares have taken a heavy hit today on the back of phase three chronic heart failure results for its rexlemestrocel-L therapy. The Mesoblast share price has tracked fairly well this year...

Ryan Clarkson-Ledward

02/12/2020

Mesoblast Share Price Up on FDA ‘Fast Track’ Designation (ASX:MSB)

At time of writing the Mesoblast Ltd [ASX:MSB] share price is up 7.26%. Soaring on the back of some exciting news. Their remestemcel-L treatment has secured ‘fast track’ status from the US Food & Drug Administration (FDA)...

Lachlann Tierney

20/11/2020

Mesoblast Share Price Up on Novartis Collaboration (ASX:MSB)

At time of writing, the share price of Mesoblast Ltd [ASX:MSB] is up more than 14%, to trade at $3.73. We take a look at the details of Mesoblast’s latest announcement to work with pharma giant on remestemcel-L commercialisation

Carl Wittkopp

11/11/2020

Mesoblast Share Price Up on Encouraging COVID-19 Trails (ASX:MSB)

At time of writing, the Mesoblast Ltd [ASX:MSB] share price is up 4.47%, trading at $3.27. The MSB share price moved higher after announcing positive outcomes in relation to Remestemcel-L phase three trials...

Ryan Clarkson-Ledward

01/10/2020

Mesoblast Enters Trading Halt — Good News on the Horizon? (ASX:MSB)

It’s no secret that Mesoblast Ltd [ASX:MSB] has been a breakout mid-cap in 2020. The stock has seen close to a fivefold (500%) increase in its share price since the March crash. Delivering some astonishing gains to shareholders who stuck with the company...

Carl Wittkopp

04/08/2020

Mesoblast Share Price Up, Nears Major Milestone (ASX:MSB)

The share price of Mesoblast Ltd [ASX:MSB] is up on the back of news the company is due to complete their first interim analysis in early September. This is for their Phase 3 trial of their lead product for COVID-19 Acute Respiratory Distress Syndrome (ARDS)...

Lachlann Tierney

24/04/2020

Coronavirus Stocks Flying Up, Mesoblast Share Price to Follow? (ASX:MSB)

Today we look at the Mesoblast Ltd [ASX:MSB] share price in light of the recent successes of other coronavirus ‘solution’ stocks. A famous quote comes to mind...‘In the midst of every crisis, lies great opportunity’ — Albert Einstein...